What are the most promising emerging therapies for sickle cell disease?

dc.contributorUniversidade Estadual Paulista (UNESP)
dc.creatorMelo, Thais Regina Ferreira de
dc.creatorChin, Chung Man
dc.creatorSantos, Jean Leandro dos
dc.date2015-11-03T15:29:48Z
dc.date2016-10-25T21:17:21Z
dc.date2015-11-03T15:29:48Z
dc.date2016-10-25T21:17:21Z
dc.date2014-01-01
dc.date.accessioned2017-04-06T09:18:25Z
dc.date.available2017-04-06T09:18:25Z
dc.identifierFuture Medicinal Chemistry. London: Future Science Ltd, v. 6, n. 9, p. 979-982, 2014.
dc.identifier1756-8919
dc.identifierhttp://hdl.handle.net/11449/130164
dc.identifierhttp://acervodigital.unesp.br/handle/11449/130164
dc.identifierhttp://dx.doi.org/10.4155/FMC.14.55
dc.identifierWOS:000346693700004
dc.identifierhttp://www.future-science.com/doi/abs/10.4155/fmc.14.55
dc.identifier.urihttp://repositorioslatinoamericanos.uchile.cl/handle/2250/940711
dc.languageeng
dc.publisherFuture Science Ltd
dc.relationFuture Medicinal Chemistry
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.subjectFetal hemoglobin inducers
dc.subjectInflammation
dc.subjectNew drugs
dc.subjectNitric oxide
dc.subjectSickle cell disease
dc.subjectVaso-occlusion
dc.titleWhat are the most promising emerging therapies for sickle cell disease?
dc.typeOtro


Este ítem pertenece a la siguiente institución